Curcumin blocks multiple sites of the TGF-β signaling cascade in renal cells

Kidney International

Volumn 66, Issue 1, 2004, Pages 112-120

  Gaedeke, Jens ^b   Noble, Nancy A ^a   Border, Wayne A ^b  

^a Fibrosis Research Laboratory   (United States)

^b NONE

Author keywords

Curcumin; Fibrosis; Kidney; RNAi; TGF beta

Indexed keywords

COLLAGEN TYPE 1; CURCUMIN; FIBRONECTIN; ISOPROTEIN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMAD2 PROTEIN; SMAD3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENETIC REGULATION; KIDNEY CELL; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TOXICITY; WESTERN BLOTTING;

CURCUMA LONGA;

EID: 3042766204     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00713.x     Document Type: Article

References (34)

1. GAEDEKE J, PETERS H, NOBLE NA, et al: Angiotensin II, TGF-β and renal fibrosis. Contrib Nephrol 135:153-160, 2001
2. BOTTINGER EP, BITZER M: TGF-beta signaling in renal disease. J Am Soc Nephrol 13:2600-2610, 2002
3. SCHNAPER HW, HAYASHIDA T, HUBCHAK SC, et al: TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 284:F243-252, 2003
4. PUNITHAVATHI D, VENKATESAN N, BABU M: Curcumin inhibition of bleomycin-induced pulmonary fibrosis in rats. Br J Pharmacol 131:169-172, 2000
5. BIERHAUS A, ZHANG Y, QUEHENBERGER P, et al: The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B. Thromb Haemost 77:772-782, 1997
6. HAHM ER, CHEON G, LEE J, et al: New and known symmetrical curcumin derivatives inhibit the formation of Fos-Jun-DNA complex. Cancer Lett 184:89-96, 2002
7. HUANG TS, LEE SC, LIN JK: Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc Natl Acad Sci USA 88:5292-5296, 1991
8. PENDURTHI UR, WILLIAMS JT, RAO LV: Inhibition of tissue factor gene activation in cultured endothelial cells by curcumin. Suppression of activation of transcription factors Egr-1, AP-1, and NF-kappa B. Arteriosder Thromb Vasc Biol 17:3406-3413, 1997
9. PETERS H, BORDER WA, NOBLE NA: Targeting TGF-beta overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade. Kidney Int 54:1570-1580, 1998
10. ELBASHIR SM, HARBORTH J, LENDECKEL W, et al: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498, 2001
11. HANNON GJ: RNA interference. Nature 418:244-251, 2002
12. NANJI AA, JOKELAINEN K, TIPOE GL, et al: Curcumin prevents alcohol induced liver disease in rats by inhibiting the expression of NF-kappa B dependent genes. Am J Physiol Gastrointest Liver Physiol 284:0321-327, 2003
13. GUKOVSKY I, REYES CN, VAQUERO EC, et al: Curcumin ameliorates ethanol and nonethanol experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol 284:G85-95, 2003
14. GADDIPATI JP, SUNDAR SV, CALEMINE J, et al: Differential regulation of cytokines and transcription factors in liver by curcumin following hemorrhage/resuscitation. Shock 19:150-156, 2003
15. WOLF G, ZIYADEH FN, STAHL RA: Angiotensin II stimulates expression of transforming growth factor beta receptor type II in cultured mouse proximal tubular cells. J Mol Med 77:556-564, 1999
16. GAEDEKE J, NOBLE NA, BORDER WA: Angiotensin II and progressive renal insufficiency. Curr Hypertens Rep 4:403-407, 2002
17. PUNITHAVATHI D, VENKATESAN N, BABU M: Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats. Br J Pharmacol 139:1342-1350, 2003
18. BHARTI AC, DONATO N, SINGH S, et al: Curcumin (diferuloyl-methane) downregulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101:1053-1062, 2003
19. HAN SS, KEUM YS, SEO HJ, et al: Curcumin suppresses activation of NfkappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J Biochem Mol Biol 35:337-342, 2002
20. JOBIN C, BRADHAM CA, RUSSO MP, et al: Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol 163:3474-3483, 1999
21. SINGH S, AGGARWAL BB: Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 270:24995-25000, 1995
22. CHUANG LY, GUH JY, LIU SF, et al: Regulation of type II transforming growth-factor-beta receptors by protein kinase C iota. Biochem J 375:385-393, 2003
23. ISAKA Y, AKAGI Y, ANDO Y, et al: Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 55:465-475, 1999
24. ATFI A, DJELLOUL S, CHASTRE E, et al: Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor beta-mediated signaling. J Biol Chem 272:1429-1432, 1997
25. HOCEVAR BA, BROWN TL, HOWE PH: TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J 18:1345-1356, 1999
26. VERRECCHIA F, VINDEVOGHEL L, LECHLEIDER RJ, et al: Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter specific manner. Oncogene 20:3332-3340, 2001
27. VERRECCHIA F, TACHEAU C, WAGNER EF, et al: A central role for the JNK pathway in mediating the antagonistic activity of proinflammatory cytokines against transforming growth factor-beta-driven SMAD3/4-specific gene expression. J Biol Chem 278:1585-1593, 2003
28. VERRECCHIA F, TACHEAU C, SCHORPP-KISTNER M, et al: Induction of the AP-1 members c-Jun and JunB by TGF-beta/Smad suppresses early Smad driven gene activation. Oncogene 20:2205-2211, 2001
29. IRESON CR, JONES DJ, ORR S, et al: Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 11:105-111, 2002
30. SHARMA RA, MCLELLAND HR, HILL KA, et al: Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 7:1894-1900, 2001
31. IRESON C, ORR S, JONES DJ, et al: Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res 61:1058-1064, 2001
32. CHENG AL, HSU CH, LIN JK, et al: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21:2895-2900, 2001
33. TONNESEN HH: Solubility, chemical and photochemical stability of curcumin in surfactant solutions. Studies of curcumin and curcuminoids, XXVIII. Pharmazie 57:820-824, 2002
34. TONNESEN HH, MASSON M, LOFTSSON T: Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: Solubility, chemical and photochemical stability. Int J Pharm 244:127-135, 2002